Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Generalized Myasthenia”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Testing effectiveness (Phase 2)Ended earlyNCT00727194
What this trial is testing

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 14
Testing effectiveness (Phase 2)Looking for participantsNCT07250750
What this trial is testing

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
ImmunAbs Inc. 96
Large-scale testing (Phase 3)Active Not RecruitingNCT05556096
What this trial is testing

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 261
Large-scale testing (Phase 3)Looking for participantsNCT06607627
What this trial is testing

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Enrolling By InvitationNCT06435312
What this trial is testing

An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 8
Large-scale testing (Phase 3)Looking for participantsNCT06744920
What this trial is testing

Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Novartis Pharmaceuticals 180
Large-scale testing (Phase 3)Study completedNCT03770403
What this trial is testing

A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness.

Who this might be right for
Generalized Myasthenia Gravis
argenx 151
Not applicableLooking for participantsNCT06064695
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
University of Missouri-Columbia 16
Early research (Phase 1)Looking for participantsNCT06626919
What this trial is testing

Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Who this might be right for
Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more
Arcellx, Inc. 30
Very early researchUnknownNCT01555580
What this trial is testing

A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Muscular Dystrophy Association 12
Very early researchLooking for participantsNCT07058298
What this trial is testing

GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Daishi Tian 6
Large-scale testing (Phase 3)Study completedNCT06471361
What this trial is testing

Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 31
Post-approval studies (Phase 4)Looking for participantsNCT06909214
What this trial is testing

Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

Who this might be right for
New Onset Generalized Myasthenia Gravis (gMG)
argenx 30
Early research (Phase 1)Looking for participantsNCT07215650
What this trial is testing

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

Who this might be right for
Generalized Myasthenia Gravis
Candid Therapeutics 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07372807
What this trial is testing

Ripertamab for the Treatment of Myasthenia Gravis

Who this might be right for
Myasthenia Gravis (MG)
Zhongming Qiu 20
Not applicableNot Yet RecruitingNCT07079020
What this trial is testing

Efgartigimod for Consolidation Therapy in gMG

Who this might be right for
Myasthenia Gravis
Da, Yuwei, M.D. 130
Large-scale testing (Phase 3)UnknownNCT05716035
What this trial is testing

Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Tang-Du Hospital 64
Testing effectiveness (Phase 2)Study completedNCT03772587
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Momenta Pharmaceuticals, Inc. 68
Large-scale testing (Phase 3)Looking for participantsNCT07039916
What this trial is testing

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Immunovant Sciences GmbH 231
Large-scale testing (Phase 3)Looking for participantsNCT06517758
What this trial is testing

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

Who this might be right for
Generalized Myasthenia Gravis
Novartis Pharmaceuticals 146
Load More Results